<< Back to Home Page
Conditions
Therapies
Products
Services
About Baxter
Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Primary Immune Deficiency patients fight off infection. Immunoglobulins are also indicated to treat a number of conditions including Kawasaki Syndrome, Chronic Lymphocytic Leukemia (CLL) and Idiopathic Thrombocytopenic Purpura (ITP).
In surgery, the ability of the surgeon to control bleeding and seal tissue quickly can help reduce complications and lead to improved surgical procedures. Baxter provides therapeutic solutions for biosurgery and tissue regeneration in many surgical specialties with biological products, preparation/delivery devices, and physician resources.
Albumin is proven effective in replacing lost fluid and maintaining adequate blood volume and pressure in critically injured patients. Baxter’s vast experience in plasma fractionation has resulted in reliable and innovative therapeutics developed from human serum albumin to support these patients.
Our long-standing commitment to provide high-quality therapies for people with hemophilia has led to innovations including recent FDA approval of the first plasma/albumin-free method recombinant Factor VIII therapy, and monoclonal antibody purification and heat treatment processes.
Renal therapies: treatments for patients with kidney failure.
Print this page
